Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| 2-Iodo-3-oxo-4-azaandrostane-17-carboxylic acid | An impurity of Finasteride. Finasteride is a 4-azasteroid analog of testosterone that competitively blocks type II 5α-reductase activity with 100-fold greater affinity than for the type I enzyme. Group: Pharmaceutical. Alternative Names: 3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic Acid. CAS No. 104239-97-6. Pack Sizes: 1mg;1g;10g. Product ID: NP3132. Molecular formula: C19H27NO3. Mole weight: 317.42. Custom synthesis is available. Send your inquiries for more information. |  London |
| 2-((Z)-5-((E)-2-methyl-3-phenylallylidene)-2,4-dioxothiazolidin-3-yl)acetic acid | An impurity of Epalrestat, a carboxylic acid-based inhibitor of aldose reductase. Group: Pharmaceutical. Alternative Names: 2-[5-((2E)-2-methyl-3-phenylprop-2-enylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]a cetic acid. CAS No. 794510-29-5. Pack Sizes: 10 mg. Product ID: B2694-343860. Molecular formula: C15H13NO4S. Mole weight: 303.3. Custom synthesis is available. Send your inquiries for more information. | London |
| (3S,5R)-Pitavastatin Calcium | A metabolite of Pitavastatin which is a potent inhibitor of HMG-CoA reductase (Ki = 1.7 nM). Group: Pharmaceutical. Alternative Names: ent-NK-104; Pitavastatin 3S,5R-Isomer Calcium Salt; (3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt. CAS No. 254452-88-5. Pack Sizes: 1 mg. Product ID: B0192-478912. Molecular formula: C25H23FNO4.1/2Ca. Mole weight: 440.86. Custom synthesis is available. Send your inquiries for more information. | London |
| (3S,5S)-Atorvastatin Acetonide tert-Butyl Ester | (3S,5S)-Atorvastatin Acetonide tert-Butyl Ester is a pharmaceutical compound employed in managing hyperlipidemia and cardiovascular disorders. It is a modified form of atorvastatin, acting as a potent HMG-CoA reductase inhibitor to mitigate cholesterol biosynthesis within hepatic cells. This medication plays a pivotal role in ameliorating lipid profiles and averting atherosclerosis progression. Uses: An intermediate for the preparation of (3s,5s)-atorvastatin. Group: Pharmaceutical. Alternative Names: (4S,6S)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester. CAS No. 472967-95-6. Pack Sizes: 25 mg. Product ID: B2692-117415. Molecular formula: C40H47FN2O5. Mole weight: 654.81. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Cyclic Isopropyl Impurity | Atorvastatin Cyclic Isopropyl Impurity is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: 4-{6-(4-Fluorophenyl)-7,8-epoxy-6-hydroxy-8a-isopropyl-7-phenyl-8-(phenylcarbamoyl)hexahydro-2H-pyrrolo[2,1-b][1,3]oxazin-2-yl}-3-. hydroxybutanoic acid; Atorvastatin epoxy pyrrolooxazin 6-hydroxy analog; Atorvastatin FXA Impurity; 3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 7-(4-fluorophenyl)hexahydro-β,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-; 7-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid. CAS No. 873950-17-5. Pack Sizes: 10 mg. Product ID: B1370-148308. Molecular formula: C33H35FN2O7. Mole weight: 590.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Ethyl Ester | Atorvastatin Ethyl Ester is the impurity of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Group: Pharmaceutical. Alternative Names: (3R,5R)-Ethyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, ethyl ester, (βR,δR)-; Ethyl (βR,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate; Ethyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate. CAS No. 1146977-93-6. Pack Sizes: 25 mg. Product ID: B2694-466959. Molecular formula: C35H39FN2O5. Mole weight: 586.71. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin Methyl Ester | Atorvastatin Methyl Ester is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: (βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Methyl Ester; (3R,5R)-Methyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbaMoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, methyl ester, (βR,δR)-; Methyl (βR,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate. CAS No. 345891-62-5. Pack Sizes: 50 mg. Product ID: B0190-466944. Molecular formula: C34H37FN2O5. Mole weight: 572.68. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide | Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide is a prominent compound in the research of dyslipidemia and associated cardiovascular disorders. Its efficacious mechanism of action lies in its tremendous capacity to inhibit HMG-CoA reductase, a pivotal enzyme profoundly engaged in the intricate process of cholesterol biosynthesis. Uses: Atorvastatin (a791750) impurity. Group: Pharmaceutical. Alternative Names: (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-heptanoic Acid Calcium Salt. CAS No. 1105067-87-5. Pack Sizes: 10 mg. Product ID: B0190-258830. Molecular formula: C40H48FN3O8?0.5Ca. Mole weight: 736.86. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound A | Atorvastatin USP Related Compound A is an impurity in the synthesis of Atorvastatin, which is a competitive HMG-CoA reductase inhibitor. Atorvastatin is a lipid-lowering medication of the statin class. Atorvastatin suppresses the production of cholesterol and prevents some cardiovascular diseases. Group: Pharmaceutical. Alternative Names: Calcium (3R,5R)-7-[2-isopropyl-4,5-diphenyl-3-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin Desfluoro impurity; (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoicacid, calcium salt; USP Atorvastatin Related Compound A; Defluoro Atorvastatin Calcium Salt; Atorvastatin Related Compound A; Calcium (3R,5R)-3,5-dihydroxy-7-(2-isopropyl-4,5-diphenyl-3-(phenylcarbamoyl)-1H-pyrrol-1-yl)heptanoate; 1H-Pyrrole-1-heptanoic acid, β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-; Calcium (βR,δR)-β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2). CAS No. 433289-83-9. Pack Sizes: 100 mg. Product ID: B0190-168852. Molecular formula: C66H70CaN4O10. Mole weight: 1119.38. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound C | Atorvastatin USP Related Compound C is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: USP Atorvastatin Related Compound C; Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin Difluoro impurity; (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt; (βR,δR)-2,3-Bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt; 1H-Pyrrole-1-heptanoic acid, 2,3-bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-; Atorvastatin Related Compound C; Difluoro Atorvastatin Calcium Salt. CAS No. 693793-53-2. Pack Sizes: 20 mg. Product ID: B2694-168854. Molecular formula: C66H66CaF4N4O10. Mole weight: 1191.32. Custom synthesis is available. Send your inquiries for more information. | London |
| Atorvastatin USP Related Compound E | Atorvastatin USP Related Compound E is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Group: Pharmaceutical. Alternative Names: USP Atorvastatin Related Compound E; Calcium (3S,5S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin 3S,5S Enantiomer; (3S,5S)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt; Atorvastatin Related Compound E; (3S,5S)-Atorvastatin Calcium Salt; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βS,δS)-. CAS No. 1105067-88-6. Pack Sizes: 5 mg. Product ID: B0190-466957. Molecular formula: C66H68CaF2N4O10. Mole weight: 1155.38. Custom synthesis is available. Send your inquiries for more information. | London |
| Des(2-methylbutyryl) Lovastatin Hydroxy Acid Sodium Salt | An impurity of Lovastatin. Lovastatin is an HMG CoA reductase inhibitor used to treat high blood cholesterol. Group: Pharmaceutical. Alternative Names: 3,5-Dihydroxy-7-(8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl)heptenoate Acid Sodium Salt; [1S-[1α(βS*,δS*),2β,6β,8β,8aα]]-1,2,6,7,8,8a-hexahydro-β,δ,8-trihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Monosodium Salt. CAS No. 132294-94-1. Pack Sizes: 10 mg. Product ID: B2694-255494. Molecular formula: C19H29O5Na. Mole weight: 360.42. Custom synthesis is available. Send your inquiries for more information. | London |
| Finasteride EP Impurity B | An intermediate in the synthesis of Finasteride. Finasteride is a 4-azasteroid analog of testosterone that competitively blocks type II 5α-reductase activity with 100-fold greater affinity than for the type I enzyme. Group: Pharmaceutical. Alternative Names: Dutasteride Methyl ester Imp; Dutasteride Ester Impurity; 4-Azaandrost-1-ene-17-carboxylic acid, 3-oxo-, methyl ester, (5α,17β)-; 17β-(Methoxycarbonyl)-4-aza-5α-androst-1-en-3-one; 1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 1,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, methyl ester, [4aR-(4aα,4bβ,6aα,7α,9aβ,9bα,11aβ)]-; 3-Oxo-4-aza-5α-androst-1-en-17β-carboxylic acid methyl ester; Methyl 3-oxo-4-aza-5α-androst-1-ene-17β-carboxylate; Dutasteride methyl ester; Finasteride Methyl Ester Analog. CAS No. 103335-41-7. Pack Sizes: 100 mg. Product ID: B2694-255935. Molecular formula: C20H29NO3. Mole weight: 331.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Ganoderic acid A | Ganoderic acid A has been reported to exhibit antitumor activity, which is mainly mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1. Uses: Anti-tumor effects, hepatoprotection, and 5-alpha reductase inhibition. Group: Pharmaceutical. Alternative Names: (7beta,15alpha,25R)-7,15-dihydroxy-3,11,23-trioxolanost-8-en-26-oic acid. CAS No. 81907-62-2. Pack Sizes: 20 mg. Product ID: NP7000. Molecular formula: C30H44O7. Mole weight: 516.67. Custom synthesis is available. Send your inquiries for more information. | London |
| Gemcitabine elaidate | Gemcitabine elaidate (also known as CO-101; CP-4126) is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Due to its lipophilicity, gemcitabine 5'-elaidic acid ester exhibits an increased cellular uptake and accumulation, resulting in an increased conversion to active metabolites, compared to gemcitabine. In addition, this formulation of gemcitabine may be less susceptible to deamination and deactivation by deoxycytidine deaminase. Group: Pharmaceutical. Alternative Names: CO-101; CO101; CO 101; CP-4126; CP4126; CP 4126. CAS No. 210829-30-4. Pack Sizes: 25 mg. Product ID: B2706-225221. Molecular formula: C27H43F2N3O5. Mole weight: 527.654. Custom synthesis is available. Send your inquiries for more information. | London |
| Leucovorin Calcium | leucovorin calcium is an active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs. Leucovorin calcium counteracts the toxic effects of these medications, 'rescuing' the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug's metabolite to its target enzyme, thus prolonging drug activity. Group: Pharmaceutical. Alternative Names: IST5-002; IST5 002; IST5002; Benzyl-AMP; N6-Benzyladenosine-5'-phosphate; Folinic acid calcium salt; Calcium Folinate. CAS No. 1492-18-8. Pack Sizes: 5 g. Product ID: B2693-301409. Molecular formula: C20H21N7O7.Ca. Mole weight: 513.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Lovastatin-[d3] | Lovastatin-[d3] is the labelled analogue of Lovastatin, which is a fungal metabolite and an inhibitor of HMG-CoA reductase. Lovastatin is an antihypercholesterolemic agent. Group: Pharmaceutical. Alternative Names: (2S)-2-(Methyl-d3)butanoic Acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro- 3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester; MK-803-d3; Lovalip-d3; Lovastatin Lactone-d3; Mevacor-d3; Mevinacor-d3. CAS No. 1002345-93-8. Pack Sizes: 1 mg. Product ID: BLP-011607. Molecular formula: C24H33D3O5. Mole weight: 407.56. Custom synthesis is available. Send your inquiries for more information. | London |
| Methotrexate disodium | Methotrexate (Amethopterin) disodium, an antimetabolite and antifolate agent, inhibits the dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis. Methotrexate disodium, also an immunosuppressant and antineoplastic agent, is used for the research of rheumatoid arthritis and a number of different cancers (such as acute lymphoblastic leukemia). Group: Pharmaceutical. Alternative Names: Amethopterin Sodium; Methotrexate Lederle; Metoart; Metotrexato Lederle; Sodium Methotrexate; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid Disodium Salt; 4-amino-n(sup10)-methyl pteroyl glutamic acid disodium salt; amethopterin sodium. CAS No. 7413-34-5. Pack Sizes: 1 g. Product ID: B1335-076226. Molecular formula: C20H20N8Na2O5. Mole weight: 498.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Methyl 3-cyclopropyl-3-oxopropionate | 3-Cyclopropyl-3-oxopropanoic Acid Methyl Ester is a reagent used in the synthesis of Pitavastatin, which is a potent HMG-CoA reductase inhibitor for hypercholesterolemia (elevated cholesterol) and prevention of cardiovascular disease. Uses: A reagent used in the synthesis of pitavastatin. Group: Pharmaceutical. Alternative Names: Methyl 2-(Cyclopropylcarbonyl)acetate; β-Oxo-cyclopropanepropanoic Acid Methyl Ester; Cyclopropanepropanoic acid, β-oxo-, methyl ester; Methyl β-oxocyclopropanepropanoate. CAS No. 32249-35-7. Pack Sizes: 1mg;1g;10g. Product ID: NP3440. Molecular formula: C7H10O3. Mole weight: 142.15. Custom synthesis is available. Send your inquiries for more information. | London |
| Pitavastatin (+)-Phenylethylamine Salt | An impurity in the synthesis of Pitavastatin, which is a HMG-CoA reductase inhibitor that lowers LDL cholesterol and triglycerides and increase HDL cholesterol in your blood. Group: Pharmaceutical. Alternative Names: (3R,5S)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptane acid (+)-phenylethylamine salt; (1R)-1-phenylethan-1-amine; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid. CAS No. 147511-70-4. Pack Sizes: 100 mg. Product ID: B1370-050088. Molecular formula: C33H35FN2O4. Mole weight: 542.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Rosuvastatin Impurity 12 | An impurity of Rosuvastatin. Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. Group: Pharmaceutical. Alternative Names: SCHEMBL1021914; SCHEMBL1022804; 2-((4R,6S)-6-((E)-2-(4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid; 894787-93-0. CAS No. 894787-93-0. Pack Sizes: 2 mg. Product ID: B2694-338785. Molecular formula: C25H32FN3O6S. Mole weight: 521.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Simvastatin Acyl-β-D-glucuronide | A metabolite of Simvastatin. Simvastatin is a lipid-lowering drug that inhibits HMG-CoA reductase. It is in the statin class of medications and works by decreasing the manufacture of cholesterol by the liver. Uses: The treatment of acute hyperammonemia. Group: Pharmaceutical. Alternative Names: Simvastatin Acyl-beta-D-glucuronide; 1-[(βR,δR,1S,2S,6R,8S,8aR)-8-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoate] β-D-Glucopyranuronic Acid. CAS No. 463962-56-3. Pack Sizes: 1mg;1g;10g. Product ID: BAT-008114. Molecular formula: C31H48O12. Mole weight: 612.71. Custom synthesis is available. Send your inquiries for more information. | London |
| Simvastatin EP Impurity F | An impurity of Simvastatin. Simvastatin is a lipid-lowering drug that inhibits HMG-CoA reductase. It is in the statin class of medications and works by decreasing the manufacture of cholesterol by the liver. Group: Pharmaceutical. Alternative Names: Simvastatin USP Related Compound F; epi-Lovastatin; Lovastatin epimer; (2R)-2-Methylbutanoic Acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester. CAS No. 79952-44-6. Pack Sizes: 50 mg. Product ID: B2694-261180. Molecular formula: C24H36O5. Mole weight: 404.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Simvastatin hydroxy acid sodium salt | A metabolite of Simvastatin. Simvastatin is a lipid-lowering drug that inhibits HMG-CoA reductase. It is in the statin class of medications and works by decreasing the manufacture of cholesterol by the liver. Group: Pharmaceutical. Alternative Names: (βR,δR,1S,2S,6R,8S,8aR)-8-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Monosodium Salt; [1S-[1α(βS*,δS*),2α,6β,8β,8aα]]-8-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Monosodium Salt; Simvastatin Sodium; Simvastatin Sodium Salt. CAS No. 101314-97-0. Pack Sizes: 100 mg. Product ID: B2694-479622. Molecular formula: C25H39O6. Na. Mole weight: 435.59 22.99. Custom synthesis is available. Send your inquiries for more information. | London |
| Warfarin | Warfarin is an anticoagulant medication commonly used to prevent and treat blood clots. Warfarin works by inhibiting vitamin K epoxide reductase, an enzyme essential for activating certain clotting factors (II, VII, IX, and X) and proteins C and S. These factors and proteins are vitamin K-dependent, and their activation is necessary for blood clotting. By inhibiting this enzyme, warfarin reduces the clotting ability of the blood. Group: Pharmaceutical. Alternative Names: 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one; Coumarin, 3-(α-acetonylbenzyl)-4-hydroxy-; (RS)-Warfarin; (±)-Warfarin; (±)-Warfarin-alcohol; 1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone; 3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin; 3-(α-Acetonylbenzyl)-4-hydroxycoumarin; 3-(α-Phenyl-β-acetylethyl)-4-hydroxycoumarin; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one; DL-3-(α-Acetonylbenzyl)-4-hydroxycoumarin; Athrombine-K; Brumolin; Circuvit; Co-Rax; Compound 42; Coumafen; Coumafene; Coumaphen; Coumefene; Dethmor; Kumader; Kumadu; Kumatox; Martefarin; NSC 59813; rac-Warfarin; Ratron; Ratron G; Rodafarin; Rodafarin C; Rodex; Temus W; Vampirinip II; Vampirinip III; W.A.R.F. 42; Warf 5; WARF compound 42; Warfarin acid; Zoocoumarin. CAS No. 81-81-2. Pack Sizes: 1mg;1g;10g. Product ID: 81-81-2. Molecular formula: C19H16O4. Mole weight: 308.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Zopolrestat | Zopolrestat is an inhibitor of Aldose Reductase(AR). It has been shown to play roles in inflammation and cancer. It is used for the treatment of diabetic nephropathy and cardiac disease. It was developed by Pfizer and was terminated in clinic phase 2 trials. Uses: Zopolrestat is used for the treatment of diabetic nephropathy and cardiac disease. Group: Pharmaceutical. Alternative Names: 3-[(5-Trifluoromethyl-2-benzothiazolyl)methyl]-3,4-dihydro-4-oxophthalazine-1-acetic acid;CP-73850;3,4-Dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid;Alond;Xedia;2-[4-Oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid;CP 73850; CP73850; CP-73850; Zopolrestat; Zopolrestatum. CAS No. 110703-94-1. Pack Sizes: 25 mg. Product ID: B0084-358923. Molecular formula: C19H12F3N3O3S. Mole weight: 419.38. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
